Record of Committee Proceedings
Joint Committee for Review of Administrative Rules
Clearinghouse Rule 20-080
Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.
Submitted by Controlled Substances Board
May 12, 2021 Referred to Joint Committee for Review of Administrative Rules
June 18, 2021 no action taken
______________________________
Adam Field
Committee Clerk